Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.

BACKGROUND: Most people with type 2 diabetes are overweight, so initial treatment is aimed at reducing weight and increasing physical activity. Even modest weight loss can improve control of blood glucose. If drug treatment is necessary, the drug of first choice is metformin. However, some people ca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Technol Assess
Main Authors: Johnston, Rhona, Uthman, Olalekan, Cummins, Ewen, Clar, Christine, Royle, Pamela, Colquitt, Jill, Tan, Bee Kang, Clegg, Andrew, Shantikumar, Saran, Court, Rachel, O'Hare, J Paul, McGrane, David, Holt, Tim, Waugh, Norman
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292646/
https://ncbi.nlm.nih.gov/pubmed/28105986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta21020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados